医学
杜瓦卢马布
卡铂
依托泊苷
间质性肺病
肺癌
肿瘤科
阶段(地层学)
内科学
肺
化疗
癌症
顺铂
免疫疗法
无容量
古生物学
生物
作者
Ryota Shibaki,Daichi Fujimoto,Eisaku Miyauchi,Yoko Tsukita,Ichiro Nakachi,Daisuke Arai,Yoshihiko Sakata,Naoki Shingu,Toshio Shimokawa,Takashi Kijima,Motohiro Tamiya,Sachiko Kawana,Satoshi Hara,Go Saito,Yuki Sato,Toshihide Yokoyama,Shinya Sakata,Yoshihiko Taniguchi,Akito Hata,Hirotaka Matsumoto
出处
期刊:Lung Cancer
[Elsevier BV]
日期:2024-09-19
卷期号:196: 107958-107958
被引量:6
标识
DOI:10.1016/j.lungcan.2024.107958
摘要
Certain guidelines recommend caution when administering immunotherapy in patients with pre-existing interstitial lung disease (ILD) owing to the high incidence of pneumonitis induced by anti-cancer therapy. A prospective clinical trial assessing the safety of chemoimmunotherapy in patients with small-cell lung cancer (SCLC) and pre-existing ILD is warranted. Therefore, this study evaluated the safety and efficacy of chemoimmunotherapy in patients with extensive-stage (ES)-SCLC and mild idiopathic interstitial pneumonia (IIP).
科研通智能强力驱动
Strongly Powered by AbleSci AI